These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 20977925)
1. Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature. Schöler N; Langer C; Döhner H; Buske C; Kuchenbauer F Exp Hematol; 2010 Dec; 38(12):1126-30. PubMed ID: 20977925 [TBL] [Abstract][Full Text] [Related]
2. microRNAs as peripheral blood biomarkers of cardiovascular disease. Di Stefano V; Zaccagnini G; Capogrossi MC; Martelli F Vascul Pharmacol; 2011 Oct; 55(4):111-8. PubMed ID: 21846509 [TBL] [Abstract][Full Text] [Related]
3. Blood cell microRNAs: what are they and what future do they hold? Ryan P; Atreya C Transfus Med Rev; 2011 Jul; 25(3):247-51. PubMed ID: 21419598 [TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Heneghan HM; Miller N; Lowery AJ; Sweeney KJ; Newell J; Kerin MJ Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314 [TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs: Association with disease and potential use as biomarkers. Reid G; Kirschner MB; van Zandwijk N Crit Rev Oncol Hematol; 2011 Nov; 80(2):193-208. PubMed ID: 21145252 [TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Gupta SK; Bang C; Thum T Circ Cardiovasc Genet; 2010 Oct; 3(5):484-8. PubMed ID: 20959591 [No Abstract] [Full Text] [Related]
7. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Wang JF; Yu ML; Yu G; Bian JJ; Deng XM; Wan XJ; Zhu KM Biochem Biophys Res Commun; 2010 Mar; 394(1):184-8. PubMed ID: 20188071 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in the kidney: novel biomarkers of acute kidney injury. Aguado-Fraile E; Ramos E; Conde E; Rodríguez M; Liaño F; García-Bermejo ML Nefrologia; 2013 Nov; 33(6):826-34. PubMed ID: 24158125 [TBL] [Abstract][Full Text] [Related]
9. [Circulating miRNAs as a new class of biomedical markers]. Baulande S; Criqui A; Duthieuw M Med Sci (Paris); 2014 Mar; 30(3):289-96. PubMed ID: 24685220 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p. Kumarswamy R; Anker SD; Thum T Circ Res; 2010 May; 106(9):e8; author reply e9. PubMed ID: 20466983 [No Abstract] [Full Text] [Related]
12. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Hanson EK; Lubenow H; Ballantyne J Anal Biochem; 2009 Apr; 387(2):303-14. PubMed ID: 19454234 [TBL] [Abstract][Full Text] [Related]
13. A truth serum for cancer--microRNAs have major potential as cancer biomarkers. Chin LJ; Slack FJ Cell Res; 2008 Oct; 18(10):983-4. PubMed ID: 18833286 [No Abstract] [Full Text] [Related]
14. The origin, function, and diagnostic potential of extracellular microRNAs in human body fluids. Liang H; Gong F; Zhang S; Zhang CY; Zen K; Chen X Wiley Interdiscip Rev RNA; 2014; 5(2):285-300. PubMed ID: 24259376 [TBL] [Abstract][Full Text] [Related]
15. MicroRNAs are novel biomarkers of colorectal cancer. Aslam MI; Taylor K; Pringle JH; Jameson JS Br J Surg; 2009 Jul; 96(7):702-10. PubMed ID: 19526617 [TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Kosaka N; Iguchi H; Ochiya T Cancer Sci; 2010 Oct; 101(10):2087-92. PubMed ID: 20624164 [TBL] [Abstract][Full Text] [Related]
17. Systemic microRNAs: novel biomarkers for colorectal and other cancers? Heneghan HM; Miller N; Kerin MJ Gut; 2010 Jul; 59(7):1002-4; author reply 1004. PubMed ID: 20581247 [No Abstract] [Full Text] [Related]
18. MicroRNAs in clinical oncology: at the crossroads between promises and problems. Metias SM; Lianidou E; Yousef GM J Clin Pathol; 2009 Sep; 62(9):771-6. PubMed ID: 19734473 [TBL] [Abstract][Full Text] [Related]